Category: WFN1 Contributors

1 2 3 84 10 / 831 POSTS
View every problem as an opportunity. Instead of looking at what has gone wrong, focus your thinking on the solution. This will move you forward with your customers and make them see you in a different light. You have an opportunity to demonstrate le ...
By John Vandermosten, CFAOTC:PMN.TO | OTC:ARFXF | NASDAQ:BIIBOn Thursday, Biogen (NASDAQ:BIIB) announced that it will discontinue its Phase 3 ENGAGE and EMERGE trials for Alzheimer’s Disease (AD) drug aducanumab. The Independent Data Monitoring Commi ...
By Ann Heffron, CFA, CPAOTC:CPKFREAD THE FULL CPKF RESEARCH REPORTChesapeake Financial’s (OTC:CPKF) fourth quarter net earnings rose 1% year over year to a record $1.85 million, while 2018’s fourth quarter diluted EPS increased by $0.01, or 1%, to $0 ...
If you were to ask somebody to describe you in one word, what would they say? How different would their word be from how you describe yourself? Your reputation is your equity. Often, it is the reason the customer responds to or ignores you. The image ...
By M. MarinNASDAQ:FUVREAD THE FULL FUV RESEARCH REPORTGreen vehicle manufacturer Arcimoto (NASDAQ:FUV), which manufactures green three-wheeled mini-vehicles, is preparing for the commercial launch of its efficient and economical product, the Fun Util ...
By Brian Marckx, CFANYSE:VNRXREAD THE FULL VNRX RESEARCH REPORTQ4 Results / Operational and Business Update:VolitionRx (NYSE:VNRX) reported Q4 financial results and provided a business update. Relative to the financials, operating expenses, at $4.3M, ...
By Brian Marckx, CFANASDAQ:VIVEREAD THE FULL VIVE RESEARCH REPORTQ4 Results: Warning Letter Headwinds Persist, Although Dissipating. 2019 Guidance Implies Much-Improved Op Loss…Viveve (NASDAQ:VIVE) reported Q4 financial results and provided a busines ...
By David Bautz, PhDNASDAQ:CFRXREAD THE FULL CFRX RESEARCH REPORTBusiness UpdateAwaiting Final Data Set for Phase 2 TrialContraFect Corp. (NASDAQ:CFRX) is developing exebacase (CF-301), the company’s lead lysin product, for the treatment of bacteremia ...
You probably don’t know your customer as well as you think you do. As a result, your business is at risk. Below are 10 questions you need to answer to know your customers, so you can better reach each of them. 1. What are my customer’s business ...
By Lisa ThompsonNYSE:DSSREAD THE FULL DSS RESEARCH REPORTDocument Security Systems, Inc. (NYSE:DSS) reported Q4 numbers in line with expectations but the 10K revealed much progress in Authentiguard. It showed revenues for that product line up were ov ...
1 2 3 84 10 / 831 POSTS